Next Quarterly Earnings
After-hours — typically from around 10:00 p.m. German time (after the US close at 4:00 p.m. New York time).
Rigel Pharmaceuticals is a US-based biopharmaceutical company dedicated to discovering, developing, and commercializing innovative medicines for patients with serious diseases. The company focuses on novel therapies in areas of high unmet medical need to improve quality of life.
After-hours — typically from around 10:00 p.m. German time (after the US close at 4:00 p.m. New York time).
Rigel Pharmaceuticals is scheduled to report its next quarterly earnings on 11/10/2026. After-hours — typically from around 10:00 p.m. German time (after the US close at 4:00 p.m. New York time).
Rigel Pharmaceuticals last reported quarterly earnings on 8/4/2026 (Q2 2026). Earnings per share (EPS) came in at 0.88 USD.
Across its last 3 earnings reports, Rigel Pharmaceuticals stock moved by ±16.2% on average the following day. The largest reaction was +33.4% on 11/04/2025; 1 of 3 reactions were positive.
Rigel Pharmaceuticals has beaten analyst EPS estimates in 4 of its last 5 evaluated quarters (beat rate: 80%).
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
Basis: price reactions to the last 3 report dates (close to close).
Basis: 5 quarters with an analyst estimate and reported EPS.
Past price reactions are not a reliable indicator of future performance.